Qualified valuation review
Measures the company’s sale value at the agreed starting date and certification date using the same method, including the agreed treatment of changes unrelated to Eumenon’s work. No sale is required.
Independent proof
Two independent tests decide whether Eumenon earns its contingent build fee.
Qualified independent review tests whether sale value reached at least 2× the agreed baseline and founder operating time fell by at least 80%. The methods are fixed before the full build, and both outcomes must pass for Eumenon to earn the $200,000 contingent fee.
Qualified independent review
Both outcomes required
90 days of stable operation
$200,000 earned only if both pass
Operating evidence shows how the two outcomes were achieved.
Eumenon measures decision coverage, founder intervention, correction rates, severe errors, escalation behavior, outcome stability, and authority limits throughout the build. Those measures determine whether the successor is ready to do more and help explain why the company changed.
- Contractual outcome 1
- Independent sale-value measurement reaches at least two times the agreed starting sale-value measure.
- Contractual outcome 2
- Independent founder-time measurement shows founder operating hours at or below 20% of the agreed baseline.
- Supporting operating evidence
- Coverage, limits, errors, recovery, continuity, and progress are preserved in the Succession Dossier to explain the operating mechanism behind both results.
- Fee rule
- Only the independent sale-value and founder-time determinations control the contingent build fee.
Qualified independent review determines whether the contingent fee was earned.
The agreed valuation and founder-time methods are applied outside Eumenon before the contingent fee is determined.
Qualified founder-time review
Measures founder operating time over the agreed baseline period, considers relevant operating history, and determines whether the stable end-state requirement was met after the build.
Fix the baselines and methods before the full build.
Starting values, scope, exclusions, records, calculations, stability conditions, and the final decision process are written down in advance so neither party can redefine success later.
- Starting sale value
- The initial independently measured sale value, effective date, included facts, and treatment of agreed market, capital, acquisition, disposition, or other unrelated change.
- Starting founder operating time
- An agreed operating-time baseline period read in the context of relevant operating history, including seasonality and non-routine demands where relevant.
- Covered operating work
- The work whose transfer must reduce founder operating time, together with excluded work, escalation rules, and the records needed to prevent superficial time displacement.
- Final determination rules
- The calculations, evidence, stability conditions, exceptions, timing, and decision process applied during the qualified independent review.
Both tests must pass.
Doubling sale value cannot make up for missing the founder-time target. Returning founder time cannot make up for missing the sale-value target.
Double what the business can sell for.
Independent qualified valuation review measures the company at the start and certification point using the same locked method.
End sale-value measure
≥ 2.00 ×
Start sale-value measure
The method specifies how unrelated changes are treated so the engagement is not credited for value that its work did not create.
Return at least 80% of founder operating time.
Independent qualified founder-time review compares the certified steady state with the agreed baseline period and relevant historical context.
End founder operating hours
≤ 20%
Baseline founder operating hours
Time counts as returned only where the defined work is actually covered under the agreed operating and escalation rules. A temporary pause in recording or founder activity does not count.
The end state must hold through the required operating period.
The standard full build uses a 90-day stability period before final measurement and an agreed 18-month deadline for the contingent result.
-
Baselines and methods fixed
The starting measures and final rules are established through qualified independent review before the full build.
-
Operating evidence accumulates
Decisions, founder interventions, corrections, outcomes, errors, recoveries, and authority changes remain traceable.
-
Coverage reaches the required end state
The successor covers the defined work while respecting exclusions, escalation, and operating limits.
-
90-day stability period
The relevant operating conditions and founder-time result must persist before final determination.
-
Independent outcome determinations
The locked methods produce pass or fail determinations within the agreed deadline.
The $200,000 contingent build fee is earned only when both outcomes pass.
This structure puts Eumenon's largest fee at risk unless both independent outcomes pass.
Sale-value test: PASS
+
Founder-time test: PASS
=
$200,000 contingent build fee earned
Either test: FAIL
=
$200,000 contingent build fee waived
The waiver applies to the contingent build fee. The $25,000 Successor Foundation fee and earned $5,000 monthly fees for managed operation remain earned.
The Succession Dossier makes the operating change reviewable.
It records what the successor can run, where authority stops, how founder involvement changed, which errors occurred, how the system recovered, and what continuity depends on after the engagement.
Open the Dossier overviewDefinitive terms, including methodology, obligations, termination, cure, timing, deferral, and payment mechanics, exist only in signed agreements.